Cargando…
The Clinical Prognostic Value of lncRNA SBF2-AS1 in Cancer Patients: A Meta-Analysis
BACKGROUND: The mortality and recurrence of patients with cancer is of high prevalence. SET-binding factor 2 (SBF2) antisense RNA1 (lncRNA-SBF2-AS1) is a promising long non-coding RNA. There is increasing evidence that SBF2-AS1 is abnormally expressed in various tumors and is associated with cancer...
Autores principales: | Wang, Jie, Zhong, Pingyong, Hua, Hao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107676/ https://www.ncbi.nlm.nih.gov/pubmed/33906548 http://dx.doi.org/10.1177/15330338211004915 |
Ejemplares similares
-
Meta-analysis of the prognostic value of lncRNA ZFAS1 in patients with solid tumors
por: Song, Wei, et al.
Publicado: (2017) -
The clinical prognostic value of lncRNA LINC00675 in cancer patients: A meta-analysis
por: Hua, Hao, et al.
Publicado: (2021) -
Prognostic value of lncRNAs in lung carcinoma: a meta-analysis
por: Fan, Fan, et al.
Publicado: (2017) -
The Prognostic Value of Expression of the Long Noncoding RNA (lncRNA) Small Nucleolar RNA Host Gene 1 (SNHG1) in Patients with Solid Malignant Tumors: A Systematic Review and Meta-Analysis
por: Xiao, Bufan, et al.
Publicado: (2018) -
The prognostic value of lncRNA AGAP2-AS1 in cancer patients: A meta-analysis
por: Zhong, Pingyong, et al.
Publicado: (2021)